Track the Bluejay Diagnostics, Inc. share price and the full insider trade history of the company, a listed equity based in United States. Shares are listed on US US, under the authority of SEC (Form 4). Operating in the Health Care sector, Bluejay Diagnostics, Inc. has published 20 public disclosures. Market capitalisation: €1.8m. The latest transaction was disclosed on 14 December 2023 (Acquisition). Among the most active insiders: Dey Svetlana. The full history is openly available.
20
Insider Decl.
0
Thresholds
€174,251
11 ops.
Buy Volume
·
0 ops.
Sell Volume
60Σ signal
Buys €174,251· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.